Detalhe da pesquisa
1.
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
N Engl J Med
; 374(17): 1647-60, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25830326
2.
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
NPJ Vaccines
; 9(1): 20, 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278816
3.
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
Lancet Infect Dis
; 20(7): 827-838, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325037
4.
PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment.
Eur Stroke J
; 3(3): 291-298, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30246150
5.
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization.
EBioMedicine
; 19: 107-118, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434944